Budesonide, Formoterol Fumarate Drug Combination
"Budesonide, Formoterol Fumarate Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
| Descriptor ID |
D000069502
|
| MeSH Number(s) |
D02.033.100.291.425.250 D02.092.063.291.425.250 D04.210.500.745.745.654.105.500 D26.310.348
|
| Concept/Terms |
Budesonide, Formoterol Fumarate Drug Combination- Budesonide, Formoterol Fumarate Drug Combination
- Budesonide Formoterol Drug Combination
- Budesonide Formoterol Fumarate Drug Combination
- Budesonide-Formoterol Drug Combination
- Combination, Budesonide-Formoterol Drug
- Drug Combination, Budesonide-Formoterol
- Budesonide-Formoterol Fumarate Drug Combination
|
Below are MeSH descriptors whose meaning is more general than "Budesonide, Formoterol Fumarate Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Budesonide, Formoterol Fumarate Drug Combination".
This graph shows the total number of publications written about "Budesonide, Formoterol Fumarate Drug Combination" by people in this website by year, and whether "Budesonide, Formoterol Fumarate Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Budesonide, Formoterol Fumarate Drug Combination" by people in Profiles.
-
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial. Ther Adv Respir Dis. 2021 Jan-Dec; 15:17534666211034329.
-
Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting ?2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Int J Chron Obstruct Pulmon Dis. 2016; 11:1921-8.
-
Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis. 2010 Oct 05; 5:357-66.